Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
Seth Boffeli, AARP Fraud Watch Network Senior Advisor, brings us a preview of tonight’s “RURAL AMERICA LIVE with AARP,” which will focus on tips for fighting fraud.
A group of 32 Democratic senators is urging ag lawmakers to halt their opposition to Prop 12 in the next Farm Bill.
In honor of Rural Road Safety Week, we’re highlighting some commonly overlooked hazards on rural roads, where 40 percent of all fatal crashes in the United States occur.
The network includes labs across the country that track diseases like New World Screwworm, which could see a rise in cases with hurricane season approaching.
Sen. Roger Marshall (R-KS) hosted the talks. The senator and doctor joined us on Wednesday on RFD-TV’s Market Day Report to recap the critical discussions surrounding human health in America.
